These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18784450)
1. Photodynamic therapy treatment for eyes with drusenoid pigment epithelium detachment. Lee NY; Kim KS Korean J Ophthalmol; 2008 Sep; 22(3):194-6. PubMed ID: 18784450 [TBL] [Abstract][Full Text] [Related]
2. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy. Arif F; Pryds A; Larsen M Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration. Pece A; Isola V; Vadalà M; Calori G Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590 [TBL] [Abstract][Full Text] [Related]
4. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for avascular serous pigment epithelial detachment in elderly Koreans. Kim KS; Lee WK Retina; 2010 Jan; 30(1):93-9. PubMed ID: 19696702 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Boscia F; Furino C; Sborgia L; Reibaldi M; Sborgia C Am J Ophthalmol; 2004 Dec; 138(6):1077-9. PubMed ID: 15629318 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Boscia F; Parodi MB; Furino C; Reibaldi M; Sborgia C Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1224-32. PubMed ID: 16525824 [TBL] [Abstract][Full Text] [Related]
8. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [TBL] [Abstract][Full Text] [Related]
10. Regression of drusen after combined treatment using photodynamic therapy with verteporfin and ranibizumab. Novais EA; Badaró E; Regatieri CV; Duker J; de Oliveira Bonomo PP Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):275-8. PubMed ID: 25707058 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for chronic serous detachment of the retinal pigment epithelium in a young patient. Olivier S; Harissi-Dagher M; Sébag M Can J Ophthalmol; 2005 Apr; 40(2):214-6. PubMed ID: 16049540 [No Abstract] [Full Text] [Related]
12. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment. Axer-Siegel R; Ehrlich R; Avisar I; Kramer M; Rosenblatt I; Priel E; Weinberger D Ophthalmic Surg Lasers Imaging; 2006; 37(6):455-61. PubMed ID: 17152538 [TBL] [Abstract][Full Text] [Related]
14. Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium. Fossarello M; Peiretti E; Zucca I; Serra A Eur J Ophthalmol; 2004; 14(6):568-71. PubMed ID: 15638110 [TBL] [Abstract][Full Text] [Related]